The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project
NCT: NCT07112365 · NOT_YET_RECRUITING
Brief Summary
This study investigates cerebrovascular reactivity (CVR) and functional brain connectivity in Dravet Syndrome (DS) patients with convulsive seizures. Using functional MRI (fMRI), we will define differences in brain responses to CO₂ changes before administration of the drug Fintepla (Baseline), with a library of healthy controls and with those obtained after administration of Fintepla (Day \~60). Changes in CVR and their relation to ventilatory responses will also be assessed during fMRI.
Frequently Asked Questions
What is The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project?
The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project is a clinical trial registered under NCT07112365. Current status: NOT_YET_RECRUITING.
What is the status of NCT07112365?
The current status of NCT07112365 (The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project) is: NOT_YET_RECRUITING.
When did The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project start?
The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project started on 2026-04.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.